Christopher Ryan Sullivan
Chief Financial Officer · 11 filings · Latest: Sep 16, 2026
Avalo Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Sep 16, 2026 | Sale | $16.33 | 12,394 | $202.4K | 39,900 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Sep 16, 2026 | Option Exercise | $9.88 | 12,394 | $122.5K | 52,294 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Sep 10, 2026 | Sale | $17.62 | 10,185 | $179.5K | 39,900 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Sep 10, 2026 | Option Exercise | $8.04 | 10,185 | $81.9K | 50,085 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Aug 18, 2026 | Sale | $20.05 | 31,031 | $622.3K | 39,900 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Aug 18, 2026 | Option Exercise | $9.88 | 31,031 | $306.6K | 70,931 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Aug 17, 2026 | Sale | $19.86 | 41,694 | $828.1K | 39,900 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Aug 17, 2026 | Option Exercise | $9.88 | 40,821 | $403.3K | 81,594 | |
AVTX | CHRISTOPHER RYAN SULLIVAN | — | Aug 18, 2026 | Proposed Sale | $20.05 | 31,031 | $622.2K | — | |
AVTX | CHRISTOPHER RYAN SULLIVAN | — | Aug 17, 2026 | Proposed Sale | $19.59 | 70,709 | $1.4M | — | |
AVTX | CHRISTOPHER RYAN SULLIVAN | — | Aug 17, 2026 | Proposed Sale | $19.94 | 3,749 | $74.8K | — | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | May 7, 2026 | Sale | $24.12 | 18,606 | $448.8K | 423 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | May 7, 2026 | Option Exercise | $9.88 | 18,606 | $183.8K | 19,029 | |
AVTX | CHRISTOPHER SULLIVAN | — | May 7, 2026 | Proposed Sale | $21.81 | 18,606 | $405.8K | — | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | May 6, 2026 | Sale | $20.19 | 47,000 | $948.7K | 423 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | May 6, 2026 | Option Exercise | $8.04 | 47,000 | $377.9K | 47,423 | |
AVTX | CHRISTOPHER SULLIVAN | — | May 6, 2026 | Proposed Sale | $16.26 | 47,000 | $764.2K | — | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Apr 30, 2026 | Sale | $13.23 | 8,457 | $111.9K | 423 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Apr 29, 2026 | Sale | $13.09 | 8,458 | $110.7K | 8,880 | |
AVTX | CHRISTOPHER SULLIVAN | — | Apr 29, 2026 | Proposed Sale | $12.86 | 16,915 | $217.5K | — |
Page 1 of 2
Next →